LEP and metabolic dysfunction-associated steatotic liver disease: These investigations have focused on molecules associated with NAFLD development, such as AMP-activated protein kinase (AMPK)-sterol regulatory element binding protein (SREBP), leptin, and secreted phosphoprotein-1 (SPP1).